Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrainger plc Regulatory News (GRI)

Share Price Information for Grainger plc (GRI)

Share Price is delayed by 15 minutes
Get Live Data
164.50    5.10 (3.20%)
Bid:
164.90
Ask:
165.10
Spread: 0.20 (0.121%)
Market Cap: £1.22b
GRI Live PriceLast checked at - London Stock Exchange

Intraday Grainger plc Share Chart

Rule 8.3- Grainger PLC

1 Aug 2008 14:03

RNS Number : 4827A
State Street Global Advisors
01 August 2008
 
 
FORM 8.3
DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE
(Rule 8.3 of the City Code on Takeovers & Mergers)
 
1. KEY INFORMATION
 
Name of Person State Street
Dealing (Note 1) Global Advisors & Affiliates

Company Dealt In Grainger PLC

Class of Relevant Security Ord
to Which the Dealings
Being Disclosed Relate (Note 2)
Date of Dealing 31/07/2008
 
2. INTERESTS, SHORT POSITIONS & RIGHTS TO SUBSCRIBE
 
 
 
(a) Interests & Short Positions (following dealing) in
the Class of Relevant Security Dealt In (Note 3)
 
Class of Relevant Security: Long Short
Number % Number %
(1) Relevant Securities 1846505 1.43990

(2) Derivatives 0 0.00000 0 0.00000

other than options

(3) Options &

Agreements to
Purchase/Sell

Total 1846505 1.43990 0 0.00000

 
(b) Interests & Short Positions in Relevant Securities of the Company
(ex.Class Dealt In) (Note 3)
 
 
Class of Relevant Security: Long Short
Number % Number %

(1) Relevant Securities

(2) Derivatives

other than options

(3) Options &

Agreements to
Purchase/Sell

Total

 
(c) Rights to Subscribe (Note 3)
 
Class of Relevant Security: Details
 
3. DEALINGS (Note 4)
 
(a) Purchases & Sales
 
Purchase / Number of Price
Sale Securities per Unit
BUY 180 2.01
 
(b) Derivatives Transactions (other than options)
 
Product Name (e.g. CFD) Long/Short No./Securites Price/Unit
(Note 6) (Note 7) (Note 5)
 
(c) Options Transactions in Respect of Existing Securities
(i) Writing, Selling, Purchasing or Varying
 
Product Name Write,Sell No/Securities Exercise Type
(eg call option) Purchasing, Which the Price (e.g. USA,
Varying etc. Optn Relates European etc)
Relates-Note7
 
Expiry Date Option Money
Paid/Received
per Unit
(Note 5)
 
(ii) Exercising
 
Product Name Number of Exercise
(eg call option) Securities Price per
Unit (Note 5)
 
(d) Other Dealings (including new securities) (Note 4)
 
Nature of Transaction Details Price / Unit
(Note 8) if applicable
(Note 5)
 
4. OTHER INFORMATION
 
(a)Agreements, Arrangements or Understandings Relating to Options or Derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing & any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced.
If none, this should be stated.
 
 
 
Is a Supplemental Form 8 Attached? (Note 9) NO
 
Disclosure Date 01/08/2008

Contact Name Harshil Naik

Telephone Number 020 7698 6213

If Connected EFM N/A
Name of Offeree/Offeror
With Which Connected
If Connected EFM N/A
State Nature of
Connection (Note 10)
 
Notes:
The Notes on Form 8.3 can be viewed on the
Takeover Panel’s website at www.thetakeoverpanel.org.uk
 
 
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETUARORWRRWRAR
Date   Source Headline
8th Oct 202510:35 amRNSDirector/PDMR Shareholding
6th Oct 20253:16 pmRNSDirector/PDMR Shareholding
3rd Oct 20254:39 pmRNSBlock Listing Return
17th Sep 20257:00 amRNS-RFull lease-up at Grainger’s Oxford BTR Scheme
10th Sep 20257:00 amRNS-RRapid 50% lease-up in under a month at Seraphina
8th Sep 20257:00 amRNSSuccessful conversion to REIT status
3rd Sep 20254:20 pmRNSDirector/PDMR Shareholding
2nd Sep 20257:00 amRNSResult of General Meeting
5th Aug 20252:45 pmRNSDirector/PDMR Shareholding
31st Jul 20257:00 amRNSChair Designate Appointment
30th Jul 202510:07 amRNSDirector/PDMR Shareholding
30th Jul 20257:00 amRNSPublication of a Circular and Notice of GM
11th Jul 20251:06 pmRNS-RMello Retail Investor Conference
9th Jul 20252:14 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNS-ROxford scheme achieves c.60% lease up in 3 months
7th Jul 20255:08 pmRNSStandard form for notification of major holdings
3rd Jul 20254:03 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNS-RConstruction completes on latest BTR scheme
24th Jun 20257:00 amRNS-RNew Progressive research note
5th Jun 202512:47 pmRNSDirector/PDMR Shareholding
4th Jun 20259:46 amRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNSSuccessful lease up at Millwrights Place
23rd May 20252:56 pmRNSDirector/PDMR Shareholding
21st May 202510:42 amRNSDirector/PDMR Shareholding
15th May 20257:00 amRNSHalf Year Financial Results
6th May 20254:57 pmRNSDirector/PDMR Shareholding
23rd Apr 20257:00 amRNSNotice of Interim Results
11th Apr 20251:34 pmRNSDirector/PDMR Shareholding
2nd Apr 20254:19 pmRNSDirector/PDMR Shareholding
1st Apr 20255:50 pmRNSBlock Listing Return
17th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20259:21 amRNS-RGrainger’s science-based target approved by SBTi
7th Mar 20251:21 pmRNSDirector/PDMR Shareholding
24th Feb 20253:50 pmRNSDirector/PDMR Shareholding
5th Feb 20253:24 pmRNSDirector/PDMR Shareholding
5th Feb 20252:47 pmRNSResult of AGM
5th Feb 20257:00 amRNSTrading Update
22nd Jan 20257:00 amRNS-RInclusion in Dow Jones Sustainability Indices
20th Jan 20258:35 amRNS-RProgressive Initiates Research Coverage
16th Jan 20254:07 pmRNSDirector/PDMR Shareholding
8th Jan 202512:27 pmRNSDirector/PDMR Shareholding
23rd Dec 202412:50 pmRNSDirector/PDMR Shareholding
23rd Dec 202412:48 pmRNSDirector/PDMR Shareholding
19th Dec 20244:42 pmRNSDirector/PDMR Shareholding
19th Dec 20244:37 pmRNSDirector/PDMR Shareholding
13th Dec 20243:50 pmRNSNotice of AGM
10th Dec 20245:24 pmRNSTotal Voting Rights
5th Dec 20244:09 pmRNSDirector/PDMR Shareholding
21st Nov 20247:00 amRNSPreliminary Full Year Financial Results
7th Nov 202412:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.